Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Viral Recombination

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.

Mismatch Repair

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Explainable machine learning in healthcare: methods, interpretation, and applications for clinical research.

Journal of the American Medical Informatics Association : JAMIA·2026

Same author

Evolving Epidemiology and Emerging Antifungal Resistance in Vulvovaginal Candidosis: Evidence from a Five-Year Survey.

Pathogens (Basel, Switzerland)·2026

Same author

Large Language Models for Clinical Narrative Processing: Methods, Applications, and Challenges.

Methods and protocols·2026

Same author

The Efficacy of Fixed-Dose Diclofenac and Orphenadrine for Postoperative Pain Management: A Systematic Review.

Medicines (Basel, Switzerland)·2026

Same author

Salmonellosis Among Children Aged 0-14 Years in Greece over the Period 2005-2024: Descriptive Analysis of Surveillance Data from the Mandatory Notification System.

Microorganisms·2026

Same author

Remdesivir: Real-World Effectiveness and Safety in Individuals Hospitalized for Non-COVID Reasons and Non-Hospitalized High-Risk Patients During the Omicron Era in Greece.

Microorganisms·2026

Same journal

Correction: Fukushima et al. Long-Term Immunogenicity of Rabies Pre-Exposure Prophylaxis in Japanese Adult Travelers: Comparison of Dosing Regimens. <i>Vaccines</i> 2025, <i>13</i>, 1169.

Vaccines·2026

Same journal

Access to Vaccines Among Asylum Seekers, Refugees, and Undocumented Migrants Across the Migratory Cycle in the European Union, European Economic Area, Switzerland and the United Kingdom: A Scoping Review.

Vaccines·2026

Same journal

Advances in Detection Methods for Human Respiratory Syncytial Virus Neutralizing Antibodies.

Vaccines·2026

Same journal

Insights from 25 Years of Measles and Measles-Rubella Vaccination Campaigns in the WHO African Region (2001-2025).

Vaccines·2026

Same journal

Post-Marketing Safety Surveillance of Influenza Vaccines in Anhui Province, China, 2016-2025.

Vaccines·2026

Same journal

Characteristics of Hypotonic-Hyporesponsive Episodes (HHEs) Following Childhood Vaccination: A 13-Year Analysis of Spontaneous Reports to the Dutch Pharmacovigilance Centre Lareb.

Vaccines·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 10, 2025

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

Vaccination Strategies: Mixing Paths Versus Matching Tracks.

Achilleas Livieratos¹, Charalambos Gogos², Iason Thomas^3,4

¹Independent Researcher, 15238 Athens, Greece.

|April 23, 2025

Summary

This summary is machine-generated.

Evaluating homologous and heterologous vaccination regimens is crucial for robust immune protection against emerging infectious diseases like SARS-CoV-2. This review examines the benefits and limitations of different vaccine mixing strategies.

Keywords:

SARS-CoV-2 adaptive immunity heterologous vaccination homologous vaccination

More Related Videos

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Related Experiment Videos

Last Updated: May 10, 2025

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Area of Science:

Immunology
Vaccinology
Infectious Diseases

Background:

Vaccination is key for immune protection.
Emerging infectious diseases like SARS-CoV-2 necessitate updated strategies.
Understanding vaccine regimen efficacy is critical.

Purpose of the Study:

To explore mechanistic insights into homologous and heterologous vaccination.
To review empirical evidence on the benefits and limitations of these approaches.
To inform optimal vaccination strategies against novel pathogens.

Main Methods:

Literature review of mechanistic studies.
Analysis of empirical data on vaccine efficacy.
Comparative evaluation of homologous and heterologous regimens.

Main Results:

Homologous vaccination provides consistent, predictable immune responses.
Heterologous vaccination can broaden immune responses and overcome limitations.
Specific pathogen and vaccine characteristics influence optimal strategy.

Conclusions:

Both homologous and heterologous vaccination strategies have distinct advantages.
Tailoring vaccine regimens based on mechanistic and empirical data is essential.
Further research is needed to optimize heterologous prime-boost approaches for emerging threats.